Table 3 Prevalence of persisting symptoms at 6 months based on gender.

From: Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

 

Women

Men

p-value

Any symptom, n (%)

59 (59.0%)

60 (40.5%)

p = 0.004

Chest symptoms, n (%)

35 (35.0%)

32 (21.6%)

p = 0.020

Dyspnoea, n (%)

29 (29.0%)

22 (14.9%)

p = 0.007

Chest pain, n (%)

7 (7.0%)

8 (5.4%)

p = 0.600

Cough, n (%)

7 (7.0%)

4 (2.7%)

p = 0.125

Extra-thoracic symptoms, n (%)

50 (50.0%)

47 (31.8%)

p = 0.004

Neurological symptoms, n (%)

26 (26%)

21 (14.2%)

p = 0.022

Anosmia, n (%)

6 (6.0%)

11 (7.4%)

p = 0.800

Agueusia, n (%)

4 (4.0%)

10 (4%)

p = 1.000

Headache, n (%)

10 (10%)

12 (4.8%)

p = 0.004

Brain fog, n (%)

5 (5%)

4 (2.7%)

p = 0.491

Diarrhea, n (%)

4 (4.0%)

0

p = 0.025

Myalgia, n (%)

5 (5.0%)

5 (3.4%)

p = 0.530

Arthralgia, n (%)

4 (4.0%)

8 (5.4%)

p = 0.767

Fatigue, n (%)

22 (22%)

18 (12.2%)

p = 0.039

Hair loss, n (%)

15 (15%)

18 (7.3%)

p < 0.001

Back to article page